Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required ) | RFA OD 22 026

Opportunity Information: Apply for RFA OD 22 026

The Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required) is a National Institutes of Health (NIH) grant opportunity designed to help outstanding postdoctoral researchers move more quickly from mentored training into independent, faculty-level research careers, specifically in the area of tobacco regulatory science. The central goal is to build and sustain a strong pipeline of new, independent investigators whose work can directly inform how tobacco products are regulated in the United States, including how regulations are developed, assessed, and refined over time. The research emphasis is on evidence that can support oversight of tobacco product manufacturing, distribution, and marketing, meaning projects should be aligned with questions relevant to real-world regulatory decisions rather than purely theoretical or exploratory topics.

This mechanism follows the classic NIH "Pathway to Independence" structure, which supports a two-stage career transition. The first stage (K99) supports a mentored postdoctoral period where the candidate deepens their expertise, publishes, builds a focused research niche, and completes targeted career development activities under the guidance of established mentors. The second stage (R00) supports the transition to an independent, tenure-track or equivalent position, providing resources for the candidate to launch their own research program as an independent investigator. The intent is that a strong K99 phase sets up a credible, competitive move into an independent role, and the R00 phase then helps establish momentum through early independent productivity, team-building, and the generation of results needed to compete for larger, long-term research awards.

A key feature of this specific announcement is that an independent clinical trial is required. In practical terms, applicants should expect that the proposed research will include a clinical trial component where the awardee, as the investigator, is responsible for planning and carrying out the trial. This requirement signals that NIH expects projects to produce high-quality human-subject evidence that can be meaningful to tobacco regulation, such as trials that evaluate behavioral, communication, product-related, or other interventions relevant to tobacco product use and regulatory policy. Because clinical trial responsibilities come with added expectations around oversight, safety monitoring, data integrity, and compliance, applicants should be prepared to demonstrate the training, mentorship, and institutional support needed to execute a trial successfully.

Eligibility for applicant organizations is broad across U.S.-based entities. Eligible applicants include various levels of government (state, county, city or township, and special district governments), federally recognized Native American tribal governments, tribal organizations that are not federally recognized, public housing authorities/Indian housing authorities, and a wide range of higher education institutions (public/state-controlled and private). Nonprofit organizations are eligible whether or not they hold 501(c)(3) status, and for-profit organizations (other than small businesses) and small businesses are also listed as eligible. The announcement also explicitly calls out additional categories of eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.

At the same time, the opportunity places clear restrictions on foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. Non-domestic components of U.S. organizations are not eligible, and foreign components, as defined by the NIH Grants Policy Statement, are not allowed. In other words, the applicant organization and the work supported by the award must be situated within allowable U.S.-based institutional structures without foreign components under NIH definitions.

From an administrative standpoint, this is a discretionary grant (FundingInstrumentType: Grant) in the health funding category, associated with CFDA number 93.077, and sponsored by the National Institutes of Health. The funding opportunity title is listed exactly as "Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)," and the funding opportunity number is RFA-OD-22-026. The original closing date provided is 2025-03-12. While the source data does not specify an award ceiling or the expected number of awards, the purpose statement makes clear that NIH is using this mechanism to cultivate a cohort of early-career researchers positioned to become long-term leaders in tobacco regulatory research.

Overall, this opportunity is best understood as a career-accelerating, mentored-to-independent bridge award for postdoctoral researchers with research and/or clinical doctorates who are ready to propose clinically oriented tobacco regulatory studies with direct relevance to FDA/NIH regulatory science priorities. It is structured to reward strong candidates who have clear potential for independence, a feasible plan to run an independent clinical trial, and a career development strategy that culminates in securing an independent faculty-equivalent position and establishing a durable research program in tobacco regulation.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required )" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.077.
• This funding opportunity was created on 2022-11-10.
• Applicants must submit their applications by 2025-03-12. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA OD 22 026

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: